Literature DB >> 32185388

Cognitive Enhancing Effect of High-Frequency Neuronavigated rTMS in Chronic Schizophrenia Patients With Predominant Negative Symptoms: A Double-Blind Controlled 32-Week Follow-up Study.

Mei Hong Xiu1, Heng Yong Guan2, Jian Min Zhao2, Ke Qiang Wang2, Yan Fen Pan2, Xiu Ru Su2, Yu Hong Wang2, Jin Ming Guo2, Long Jiang2, Hong Yu Liu2, Shi Guang Sun2, Hao Ran Wu2, Han Song Geng2, Xiao Wen Liu2, Hui Jing Yu2, Bao Chun Wei2, Xi Po Li2, Tammy Trinh3, Shu Ping Tan1, Xiang Yang Zhang4,5.   

Abstract

Accumulating studies have shown that high-frequency (HF) repetitive transcranial magnetic stimulation (rTMS) may improve cognitive dysfunction of the patients with schizophrenia (SCZ), but with inconsistent results. The present study aims to assess the efficacy of different frequencies of neuronavigated rTMS in ameliorating cognitive impairments and alleviating the psychotic symptoms. A total of 120 patients were randomly assigned to 3 groups: 20 Hz rTMS (n = 40), 10 Hz rTMS (n = 40), or sham stimulation (n = 40) for 8 weeks, and then followed up at week 32. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) was performed to assess the cognitive functions of the patients at baseline, at the end of week 8, and week 32 follow-up. Psychotic symptoms were assessed with the Positive and Negative Syndrome Scale (PANSS) at baseline and at the end of week 2, week 4, week 6, week 8, and week 32 follow-up. Our results demonstrated that 20 Hz rTMS treatment produced an effective therapeutic benefit on immediate memory of patients with chronic SCZ at week 8, but not in the 10 Hz group. Interestingly, both 10 Hz and 20 Hz rTMS treatments produced delayed effects on cognitive functions at the 6-month follow-up. Moreover, in both 10 Hz rTMS and 20 Hz rTMS, the improvements in RBANS total score were positively correlated with the reduction of PANSS positive subscore at the 6-month follow-up. Stepwise regression analysis identified that the visuospatial/constructional index, immediate memory index, and prolactin at baseline were predictors for the improvement of cognitive impairments in the patients. Our results suggest that add-on HF rTMS could be an effective treatment for cognitive impairments in patients with chronic SCZ, with a delayed effect. Trial registration: clinicaltrials.gov identifier-NCT03774927.
© The Author(s) 2020. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center.All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  cognition; immediate memory; rTMS; randomized controlled trial; schizophrenia

Year:  2020        PMID: 32185388      PMCID: PMC7505170          DOI: 10.1093/schbul/sbaa035

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  61 in total

Review 1.  The treatment of cognitive impairment in schizophrenia.

Authors:  Donald C Goff; Michele Hill; Deanna Barch
Journal:  Pharmacol Biochem Behav       Date:  2010-11-27       Impact factor: 3.533

2.  Optimal transcranial magnetic stimulation coil placement for targeting the dorsolateral prefrontal cortex using novel magnetic resonance image-guided neuronavigation.

Authors:  Pablo M Rusjan; Mera S Barr; Faranak Farzan; Tamara Arenovich; Jerome J Maller; Paul B Fitzgerald; Zafiris J Daskalakis
Journal:  Hum Brain Mapp       Date:  2010-11       Impact factor: 5.038

3.  Should we expand the toolbox of psychiatric treatment methods to include Repetitive Transcranial Magnetic Stimulation (rTMS)? A meta-analysis of the efficacy of rTMS in psychiatric disorders.

Authors:  Christina W Slotema; Jan Dirk Blom; Hans W Hoek; Iris E C Sommer
Journal:  J Clin Psychiatry       Date:  2010-03-09       Impact factor: 4.384

Review 4.  Effects of online repetitive transcranial magnetic stimulation (rTMS) on cognitive processing: A meta-analysis and recommendations for future studies.

Authors:  Lysianne Beynel; Lawrence G Appelbaum; Bruce Luber; Courtney A Crowell; Susan A Hilbig; Wesley Lim; Duy Nguyen; Nicolas A Chrapliwy; Simon W Davis; Roberto Cabeza; Sarah H Lisanby; Zhi-De Deng
Journal:  Neurosci Biobehav Rev       Date:  2019-08-29       Impact factor: 8.989

5.  A randomized controlled trial of sequentially bilateral prefrontal cortex repetitive transcranial magnetic stimulation in the treatment of negative symptoms in schizophrenia.

Authors:  Mera S Barr; Faranak Farzan; Lisa C Tran; Paul B Fitzgerald; Zafiris J Daskalakis
Journal:  Brain Stimul       Date:  2011-07-13       Impact factor: 8.955

6.  Easy methods to make the neuronavigated targeting of DLPFC accurate and routinely accessible for rTMS.

Authors:  Benjamin Pommier; François Vassal; Claire Boutet; Sophie Jeannin; Roland Peyron; Isabelle Faillenot
Journal:  Neurophysiol Clin       Date:  2017-02-13       Impact factor: 3.734

7.  Predictors for improvement of problem-solving during cognitive remediation for patients with Schizophrenia.

Authors:  Katlehn Rodewald; Daniel V Holt; Mirjam Rentrop; Daniela Roesch-Ely; Michael Liebrenz; Joachim Funke; Matthias Weisbrod; Stefan Kaiser
Journal:  J Int Neuropsychol Soc       Date:  2014-03-03       Impact factor: 2.892

8.  Hypofrontality in schizophrenia: a meta-analysis of functional imaging studies.

Authors:  K Hill; L Mann; K R Laws; C M E Stephenson; I Nimmo-Smith; P J McKenna
Journal:  Acta Psychiatr Scand       Date:  2004-10       Impact factor: 6.392

9.  Schizophrenia is a cognitive illness: time for a change in focus.

Authors:  René S Kahn; Richard S E Keefe
Journal:  JAMA Psychiatry       Date:  2013-10       Impact factor: 21.596

Review 10.  A review of brain stimulation methods to treat substance use disorders.

Authors:  Alexandria S Coles; Karolina Kozak; Tony P George
Journal:  Am J Addict       Date:  2018-02-19
View more
  8 in total

1.  Magnetic Resonance Imaging-Guided and Navigated Individualized Repetitive Transcranial Magnetic Stimulation for Cognitive Impairment in Schizophrenia.

Authors:  Xu-Sha Wu; Tian-Cai Yan; Xian-Yang Wang; Yang Cao; Xiao-Fan Liu; Yu-Fei Fu; Lin Wu; Yin-Chuan Jin; Hong Yin; Long-Biao Cui
Journal:  Neurosci Bull       Date:  2021-06-18       Impact factor: 5.271

2.  Relationships between abnormal neural activities and cognitive impairments in patients with drug-naive first-episode schizophrenia.

Authors:  Wei Yan; Rongrong Zhang; Min Zhou; Shuiping Lu; Wenmei Li; Shiping Xie; Ning Zhang
Journal:  BMC Psychiatry       Date:  2020-06-05       Impact factor: 3.630

3.  The Association Between Lentiform Nucleus Function and Cognitive Impairments in Schizophrenia.

Authors:  Ping Li; Shu-Wan Zhao; Xu-Sha Wu; Ya-Juan Zhang; Lei Song; Lin Wu; Xiao-Fan Liu; Yu-Fei Fu; Di Wu; Wen-Jun Wu; Ya-Hong Zhang; Hong Yin; Long-Biao Cui; Fan Guo
Journal:  Front Hum Neurosci       Date:  2021-10-21       Impact factor: 3.473

4.  rTMS Induces Brain Functional and Structural Alternations in Schizophrenia Patient With Auditory Verbal Hallucination.

Authors:  Yuanjun Xie; Muzhen Guan; Zhongheng Wang; Zhujing Ma; Huaning Wang; Peng Fang; Hong Yin
Journal:  Front Neurosci       Date:  2021-09-01       Impact factor: 4.677

5.  Detection of Schizophrenia Cases From Healthy Controls With Combination of Neurocognitive and Electrophysiological Features.

Authors:  Qing Tian; Ning-Bo Yang; Yu Fan; Fang Dong; Qi-Jing Bo; Fu-Chun Zhou; Ji-Cong Zhang; Liang Li; Guang-Zhong Yin; Chuan-Yue Wang; Ming Fan
Journal:  Front Psychiatry       Date:  2022-04-05       Impact factor: 5.435

6.  The optimum parameters and neuroimaging mechanism of repetitive transcranial magnetic stimulation to post-stroke cognitive impairment, a protocol of an orthogonally-designed randomized controlled trial.

Authors:  Ling-Xin Li; Jing-Kang Lu; Bao-Jin Li; Qiang Gao; Cheng-Qi He; Shi-Hong Zhang; You-Jin Zhao; Shuai He; Qian Wen
Journal:  PLoS One       Date:  2022-07-21       Impact factor: 3.752

7.  Repetitive transcranial magnetic stimulation for psychiatric symptoms in long-term hospitalized veterans with schizophrenia: A randomized double-blind controlled trial.

Authors:  Xiuru Su; Long Zhao; Yujie Shang; Yingnan Chen; Xiaowen Liu; Xuan Wang; Meihong Xiu; Huijing Yu; Lijun Liu
Journal:  Front Psychiatry       Date:  2022-09-23       Impact factor: 5.435

8.  Repetitive Transcranial Magnetic Stimulation Improves Brain-Derived Neurotrophic Factor and Cholinergic Signaling in the 3xTgAD Mouse Model of Alzheimer's Disease.

Authors:  M Windy McNerney; Alesha Heath; Sindhu K Narayanan; Jerome Yesavage
Journal:  J Alzheimers Dis       Date:  2022       Impact factor: 4.160

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.